case_images: PMC9480580_01
case_images: Target lesions at baseline. Target lesions at the vaginal stump and in front of rectum was 44 mm in longest diameter at baseline (red arrow).
case_images: OTT-15-973-g0001.jpg
case_images: PMC9480580_01_OTT-15-973-g0001.jpg
case_images: f0001
case_images: At baseline, the diameter of target lesions at the vaginal stump and in front of rectum was 44 mm (Figure 1), and multiple lymph nodes below 8 mm in the internal iliac vessel region were observed for non-target lesions (Figure 2).
case_images: Non-target lesions at baseline. Multiple lymph nodes below 8 mm in the internal iliac vessel region were observed for non-target lesions at baseline (red arrow).
case_images: OTT-15-973-g0002.jpg
case_images: PMC9480580_01_OTT-15-973-g0002.jpg
case_images: f0002
case_images: At baseline, the diameter of target lesions at the vaginal stump and in front of rectum was 44 mm (Figure 1), and multiple lymph nodes below 8 mm in the internal iliac vessel region were observed for non-target lesions (Figure 2).
case_images: Non-target lesions at the end of the 4th cycle. Non-target lesions disappeared at the end of the 4th cycle of treatment and did not recur (red arrow).
case_images: OTT-15-973-g0003.jpg
case_images: PMC9480580_01_OTT-15-973-g0003.jpg
case_images: f0003
case_images: After the 4th cycle of treatment, non-target lesions disappeared and did not recur (Figure 3).
case_images: Target lesions at the end of the 11th cycle. Target lesions at the vaginal stump and in front of rectum reduced to 3.9 mm in longest diameter at the end of the 11th cycle (red arrow), which sharply decreased by 91.14%.
case_images: OTT-15-973-g0004.jpg
case_images: PMC9480580_01_OTT-15-973-g0004.jpg
case_images: f0004
case_images: At the end of the 11th cycle, the diameter of target lesions reduced to 3.9 mm without significant change thereafter (Figure 4).